Annual report

Period2022-07-01 → 2023-06-30
Filed2023-09-28
StandardJapan GAAP
ConsolidatedYes
Data checks24 of 24 passed
Key figures · 148
MetricValuePeriodScopeSource row
Revenue¥8.1bn2022-07-01 → 2023-06-30Cons.Net sales
Revenue¥9.3bn2021-07-01 → 2022-06-30Cons.Net sales
Revenue¥8.9bn2020-07-01 → 2021-06-30dCons.Net sales (5-year summary)
Revenue¥9.3bn2019-07-01 → 2020-06-30dCons.Net sales (5-year summary)
Revenue¥7.6bn2018-07-01 → 2019-06-30dCons.Net sales (5-year summary)
Operating income¥726m2022-07-01 → 2023-06-30Cons.Operating income
Operating income¥1.2bn2021-07-01 → 2022-06-30Cons.Operating income
Ordinary income¥727m2022-07-01 → 2023-06-30Cons.Ordinary income
Ordinary income¥1.3bn2021-07-01 → 2022-06-30Cons.Ordinary income
Ordinary income¥920m2020-07-01 → 2021-06-30dCons.Ordinary income loss (5-year summary)
Ordinary income¥1.1bn2019-07-01 → 2020-06-30dCons.Ordinary income loss (5-year summary)
Ordinary income¥878m2018-07-01 → 2019-06-30dCons.Ordinary income loss (5-year summary)
Profit before tax¥725m2022-07-01 → 2023-06-30Cons.Income before income taxes
Profit before tax¥1.3bn2021-07-01 → 2022-06-30Cons.Income before income taxes
Net income (owners)¥452m2022-07-01 → 2023-06-30Cons.Profit loss attributable to owners of parent
Net income (owners)¥810m2021-07-01 → 2022-06-30Cons.Profit loss attributable to owners of parent
Net income (owners)¥562m2020-07-01 → 2021-06-30dCons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥732m2019-07-01 → 2020-06-30dCons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥553m2018-07-01 → 2019-06-30dCons.Profit loss attributable to owners of parent (5-year summary)
Net income¥456m2022-07-01 → 2023-06-30Cons.Profit loss
Net income¥817m2021-07-01 → 2022-06-30Cons.Profit loss
Total assets¥8.2bnat 2023-06-30Cons.Assets
Total assets¥8.5bnat 2022-06-30Cons.Assets
Total assets¥7.1bnat 2021-06-30dCons.Total assets (5-year summary)
Total assets¥7.4bnat 2020-06-30dCons.Total assets (5-year summary)
Total assets¥6.3bnat 2019-06-30dCons.Total assets (5-year summary)
Total liabilities¥1.1bnat 2023-06-30Cons.Liabilities
Total liabilities¥1.6bnat 2022-06-30Cons.Liabilities
Net assets / equity¥7.2bnat 2023-06-30Cons.Net assets
Net assets / equity¥6.8bnat 2022-06-30Cons.Net assets
Net assets / equity¥6.2bnat 2021-06-30dCons.Net assets
Net assets / equity¥5.8bnat 2020-06-30dCons.Net assets (5-year summary)
Net assets / equity¥5.2bnat 2019-06-30dCons.Net assets (5-year summary)
Cash and deposits¥5.9bnat 2023-06-30Cons.Cash and deposits
Cash and deposits¥6.0bnat 2022-06-30Cons.Cash and deposits
Cash & equivalents¥5.9bnat 2023-06-30Cons.Cash and cash equivalents
Cash & equivalents¥6.0bnat 2022-06-30Cons.Cash and cash equivalents
Cash & equivalents¥4.3bnat 2021-06-30dCons.Cash and cash equivalents
Cash & equivalents¥4.5bnat 2020-06-30dCons.Cash and cash equivalents (5-year summary)
Cash & equivalents¥3.1bnat 2019-06-30dCons.Cash and cash equivalents (5-year summary)
Operating cash flow−¥102m2022-07-01 → 2023-06-30Cons.Net cash provided by used in operating activities
Operating cash flow¥2.1bn2021-07-01 → 2022-06-30Cons.Net cash provided by used in operating activities
Operating cash flow−¥107m2020-07-01 → 2021-06-30dCons.Net cash provided by used in operating activities (5-year summary)
Operating cash flow¥830m2019-07-01 → 2020-06-30dCons.Net cash provided by used in operating activities (5-year summary)
Operating cash flow¥469m2018-07-01 → 2019-06-30dCons.Net cash provided by used in operating activities (5-year summary)
Investing cash flow¥160m2022-07-01 → 2023-06-30Cons.Net cash provided by used in investment activities
Investing cash flow−¥245m2021-07-01 → 2022-06-30Cons.Net cash provided by used in investment activities
Investing cash flow−¥25m2020-07-01 → 2021-06-30dCons.Net cash provided by used in investing activities (5-year summary)
Investing cash flow¥693m2019-07-01 → 2020-06-30dCons.Net cash provided by used in investing activities (5-year summary)
Investing cash flow−¥289m2018-07-01 → 2019-06-30dCons.Net cash provided by used in investing activities (5-year summary)
Financing cash flow−¥130m2022-07-01 → 2023-06-30Cons.Net cash provided by used in financing activities
Financing cash flow−¥130m2021-07-01 → 2022-06-30Cons.Net cash provided by used in financing activities
Financing cash flow−¥131m2020-07-01 → 2021-06-30dCons.Net cash provided by used in financing activities (5-year summary)
Financing cash flow−¥103m2019-07-01 → 2020-06-30dCons.Net cash provided by used in financing activities (5-year summary)
Financing cash flow−¥52m2018-07-01 → 2019-06-30dCons.Net cash provided by used in financing activities (5-year summary)
EPS (basic)¥17.272022-07-01 → 2023-06-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥30.952021-07-01 → 2022-06-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥21.492020-07-01 → 2021-06-30dCons.Basic earnings loss per share (5-year summary)
EPS (basic)¥27.972019-07-01 → 2020-06-30dCons.Basic earnings loss per share (5-year summary)
EPS (basic)¥21.162018-07-01 → 2019-06-30dCons.Basic earnings loss per share (5-year summary)
Net assets per share¥266.41at 2023-06-30Cons.Net assets per share (5-year summary)
Net assets per share¥254.14at 2022-06-30Cons.Net assets per share (5-year summary)
Net assets per share¥230.88at 2021-06-30dCons.Net assets per share (5-year summary)
Net assets per share¥214.39at 2020-06-30dCons.Net assets per share (5-year summary)
Net assets per share¥190.87at 2019-06-30dCons.Net assets per share (5-year summary)
Equity ratio84.6%at 2023-06-30Cons.Equity to asset ratio (5-year summary)
Equity ratio78.3%at 2022-06-30Cons.Equity to asset ratio (5-year summary)
Equity ratio84.5%at 2021-06-30dCons.Equity to asset ratio (5-year summary)
Equity ratio75.7%at 2020-06-30dCons.Equity to asset ratio (5-year summary)
Equity ratio79.5%at 2019-06-30dCons.Equity to asset ratio (5-year summary)
ROE6.6%2022-07-01 → 2023-06-30Cons.Rate of return on equity (5-year summary)
ROE12.8%2021-07-01 → 2022-06-30Cons.Rate of return on equity (5-year summary)
ROE9.7%2020-07-01 → 2021-06-30dCons.Rate of return on equity (5-year summary)
ROE13.8%2019-07-01 → 2020-06-30dCons.Rate of return on equity (5-year summary)
ROE11.7%2018-07-01 → 2019-06-30dCons.Rate of return on equity (5-year summary)
Employees98at 2023-06-30Cons.Number of employees
Employees100at 2022-06-30Cons.Number of employees
Employees104at 2021-06-30dCons.Number of employees
Employees105at 2020-06-30dCons.Number of employees
Employees101at 2019-06-30dCons.Number of employees
Revenue¥377m2022-07-01 → 2023-06-30StandaloneNet sales
Revenue¥439m2021-07-01 → 2022-06-30StandaloneNet sales
Revenue¥425m2020-07-01 → 2021-06-30dStandaloneNet sales (5-year summary)
Revenue¥425m2019-07-01 → 2020-06-30dStandaloneNet sales (5-year summary)
Revenue¥303m2018-07-01 → 2019-06-30dStandaloneNet sales (5-year summary)
Operating income¥81m2022-07-01 → 2023-06-30StandaloneOperating income
Operating income¥134m2021-07-01 → 2022-06-30StandaloneOperating income
Ordinary income¥87m2022-07-01 → 2023-06-30StandaloneOrdinary income
Ordinary income¥137m2021-07-01 → 2022-06-30StandaloneOrdinary income
Ordinary income¥132m2020-07-01 → 2021-06-30dStandaloneOrdinary income loss (5-year summary)
Ordinary income¥116m2019-07-01 → 2020-06-30dStandaloneOrdinary income loss (5-year summary)
Ordinary income¥73m2018-07-01 → 2019-06-30dStandaloneOrdinary income loss (5-year summary)
Profit before tax¥87m2022-07-01 → 2023-06-30StandaloneIncome before income taxes
Profit before tax¥137m2021-07-01 → 2022-06-30StandaloneIncome before income taxes
Net income¥142m2022-07-01 → 2023-06-30StandaloneProfit loss
Net income¥195m2021-07-01 → 2022-06-30StandaloneProfit loss
Net income¥288m2020-07-01 → 2021-06-30dStandaloneNet income loss (5-year summary)
Net income¥155m2019-07-01 → 2020-06-30dStandaloneNet income loss (5-year summary)
Net income¥111m2018-07-01 → 2019-06-30dStandaloneNet income loss (5-year summary)
Total assets¥4.3bnat 2023-06-30StandaloneAssets
Total assets¥4.5bnat 2022-06-30StandaloneAssets
Total assets¥4.2bnat 2021-06-30dStandaloneTotal assets (5-year summary)
Total assets¥4.1bnat 2020-06-30dStandaloneTotal assets (5-year summary)
Total assets¥4.0bnat 2019-06-30dStandaloneTotal assets (5-year summary)
Total liabilities¥21mat 2023-06-30StandaloneLiabilities
Total liabilities¥196mat 2022-06-30StandaloneLiabilities
Net assets / equity¥4.3bnat 2023-06-30StandaloneNet assets
Net assets / equity¥4.3bnat 2022-06-30StandaloneNet assets
Net assets / equity¥4.2bnat 2021-06-30dStandaloneNet assets
Net assets / equity¥4.1bnat 2020-06-30dStandaloneNet assets (5-year summary)
Net assets / equity¥4.0bnat 2019-06-30dStandaloneNet assets (5-year summary)
Cash and deposits¥1.3bnat 2023-06-30StandaloneCash and deposits
Cash and deposits¥1.1bnat 2022-06-30StandaloneCash and deposits
EPS (basic)¥5.442022-07-01 → 2023-06-30StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥7.472021-07-01 → 2022-06-30StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥11.022020-07-01 → 2021-06-30dStandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥5.912019-07-01 → 2020-06-30dStandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥4.262018-07-01 → 2019-06-30dStandaloneBasic earnings loss per share (5-year summary)
Dividend per share¥52022-07-01 → 2023-06-30StandaloneDividend paid per share (5-year summary)
Dividend per share¥52021-07-01 → 2022-06-30StandaloneDividend paid per share (5-year summary)
Dividend per share¥52020-07-01 → 2021-06-30dStandaloneDividend paid per share (5-year summary)
Dividend per share¥52019-07-01 → 2020-06-30dStandaloneDividend paid per share (5-year summary)
Dividend per share¥42018-07-01 → 2019-06-30dStandaloneDividend paid per share (5-year summary)
Net assets per share¥163.95at 2023-06-30StandaloneNet assets per share (5-year summary)
Net assets per share¥163.52at 2022-06-30StandaloneNet assets per share (5-year summary)
Net assets per share¥161.05at 2021-06-30dStandaloneNet assets per share (5-year summary)
Net assets per share¥155.03at 2020-06-30dStandaloneNet assets per share (5-year summary)
Net assets per share¥153.56at 2019-06-30dStandaloneNet assets per share (5-year summary)
Equity ratio99.5%at 2023-06-30StandaloneEquity to asset ratio (5-year summary)
Equity ratio95.6%at 2022-06-30StandaloneEquity to asset ratio (5-year summary)
Equity ratio99.5%at 2021-06-30dStandaloneEquity to asset ratio (5-year summary)
Equity ratio99.6%at 2020-06-30dStandaloneEquity to asset ratio (5-year summary)
Equity ratio99.3%at 2019-06-30dStandaloneEquity to asset ratio (5-year summary)
ROE3.3%2022-07-01 → 2023-06-30StandaloneRate of return on equity (5-year summary)
ROE4.6%2021-07-01 → 2022-06-30StandaloneRate of return on equity (5-year summary)
ROE7.0%2020-07-01 → 2021-06-30dStandaloneRate of return on equity (5-year summary)
ROE3.8%2019-07-01 → 2020-06-30dStandaloneRate of return on equity (5-year summary)
ROE2.8%2018-07-01 → 2019-06-30dStandaloneRate of return on equity (5-year summary)
Shares issued26,158,200at 2023-06-30StandaloneTotal number of issued shares (5-year summary)
Shares issued26,158,200at 2022-06-30StandaloneTotal number of issued shares (5-year summary)
Shares issued26,158,200at 2021-06-30dStandaloneTotal number of issued shares (5-year summary)
Shares issued26,158,200at 2020-06-30dStandaloneTotal number of issued shares (5-year summary)
Shares issued26,158,200at 2019-06-30dStandaloneTotal number of issued shares (5-year summary)
Employees7at 2023-06-30StandaloneNumber of employees
Employees9at 2022-06-30StandaloneNumber of employees
Employees8at 2021-06-30dStandaloneNumber of employees
Employees8at 2020-06-30dStandaloneNumber of employees
Employees7at 2019-06-30dStandaloneNumber of employees

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 92
SegmentItemPeriodValue
Reconciling Itemsreconcilingcapex2022-07-01 → 2023-06-30¥244,000
Reconciling Itemsreconcilingdepreciation2022-07-01 → 2023-06-30¥217,000
Reconciling Itemsreconcilingrevenue2022-07-01 → 2023-06-30−¥25m
Reconciling Itemsreconcilingrevenue external2022-07-01 → 2023-06-30¥2m
Reconciling Itemsreconcilingrevenue intersegment2022-07-01 → 2023-06-30−¥26m
Reconciling Itemsreconcilingsegment assetsat 2023-06-30¥1.5bn
Reconciling Itemsreconcilingsegment profit2022-07-01 → 2023-06-30−¥294m
Clinical Evidence Servicereportable segmentcapex2022-07-01 → 2023-06-30¥8m
Clinical Evidence Servicereportable segmentdepreciation2022-07-01 → 2023-06-30¥4m
Clinical Evidence Servicereportable segmentemployeesat 2023-06-3020 pure
Clinical Evidence Servicereportable segmentrevenue2022-07-01 → 2023-06-30¥617m
Clinical Evidence Servicereportable segmentrevenue external2022-07-01 → 2023-06-30¥602m
Clinical Evidence Servicereportable segmentrevenue intersegment2022-07-01 → 2023-06-30¥15m
Clinical Evidence Servicereportable segmentsegment assetsat 2023-06-30¥427m
Clinical Evidence Servicereportable segmentsegment profit2022-07-01 → 2023-06-30¥89m
Functional Cosmetic Retailingreportable segmentcapex2022-07-01 → 2023-06-30¥29m
Functional Cosmetic Retailingreportable segmentdepreciation2022-07-01 → 2023-06-30¥13m
Functional Cosmetic Retailingreportable segmentemployeesat 2023-06-3029 pure
Functional Cosmetic Retailingreportable segmentrevenue2022-07-01 → 2023-06-30¥3.9bn
Functional Cosmetic Retailingreportable segmentrevenue external2022-07-01 → 2023-06-30¥3.9bn
Functional Cosmetic Retailingreportable segmentsegment assetsat 2023-06-30¥3.3bn
Functional Cosmetic Retailingreportable segmentsegment profit2022-07-01 → 2023-06-30¥658m
Functional Food Retailingreportable segmentcapex2022-07-01 → 2023-06-30¥3m
Functional Food Retailingreportable segmentdepreciation2022-07-01 → 2023-06-30¥5m
Functional Food Retailingreportable segmentemployeesat 2023-06-3025 pure
Functional Food Retailingreportable segmentrevenue2022-07-01 → 2023-06-30¥2.5bn
Functional Food Retailingreportable segmentrevenue external2022-07-01 → 2023-06-30¥2.5bn
Functional Food Retailingreportable segmentsegment assetsat 2023-06-30¥1.3bn
Functional Food Retailingreportable segmentsegment profit2022-07-01 → 2023-06-30¥137m
Functional Material Developmentreportable segmentdepreciation2022-07-01 → 2023-06-30¥1m
Functional Material Developmentreportable segmentemployeesat 2023-06-309 pure
Functional Material Developmentreportable segmentrevenue2022-07-01 → 2023-06-30¥501m
Functional Material Developmentreportable segmentrevenue external2022-07-01 → 2023-06-30¥490m
Functional Material Developmentreportable segmentrevenue intersegment2022-07-01 → 2023-06-30¥11m
Functional Material Developmentreportable segmentsegment assetsat 2023-06-30¥1.4bn
Functional Material Developmentreportable segmentsegment profit2022-07-01 → 2023-06-30¥43m
Health Care Support Servicereportable segmentdepreciation2022-07-01 → 2023-06-30¥935,000
Health Care Support Servicereportable segmentemployeesat 2023-06-308 pure
Health Care Support Servicereportable segmentrevenue2022-07-01 → 2023-06-30¥553m
Health Care Support Servicereportable segmentrevenue external2022-07-01 → 2023-06-30¥553m
Health Care Support Servicereportable segmentsegment assetsat 2023-06-30¥315m
Health Care Support Servicereportable segmentsegment profit2022-07-01 → 2023-06-30¥93m
—segment totalcapex2022-07-01 → 2023-06-30¥39m
—segment totaldepreciation2022-07-01 → 2023-06-30¥25m
—segment totalrevenue2022-07-01 → 2023-06-30¥8.1bn
—segment totalrevenue external2022-07-01 → 2023-06-30¥8.1bn
—segment totalrevenue intersegment2022-07-01 → 2023-06-30¥26m
—segment totalsegment assetsat 2023-06-30¥6.8bn
—segment totalsegment profit2022-07-01 → 2023-06-30¥1.0bn
Reconciling Itemsreconcilingdepreciation2021-07-01 → 2022-06-30¥237,000
Reconciling Itemsreconcilingrevenue2021-07-01 → 2022-06-30−¥9m
Reconciling Itemsreconcilingrevenue external2021-07-01 → 2022-06-30¥2m
Reconciling Itemsreconcilingrevenue intersegment2021-07-01 → 2022-06-30−¥11m
Reconciling Itemsreconcilingsegment assetsat 2022-06-30¥1.3bn
Reconciling Itemsreconcilingsegment profit2021-07-01 → 2022-06-30−¥304m
Clinical Evidence Servicereportable segmentcapex2021-07-01 → 2022-06-30¥5m
Clinical Evidence Servicereportable segmentdepreciation2021-07-01 → 2022-06-30¥2m
Clinical Evidence Servicereportable segmentrevenue2021-07-01 → 2022-06-30¥552m
Clinical Evidence Servicereportable segmentrevenue external2021-07-01 → 2022-06-30¥552m
Clinical Evidence Servicereportable segmentsegment assetsat 2022-06-30¥453m
Clinical Evidence Servicereportable segmentsegment profit2021-07-01 → 2022-06-30¥6m
Functional Cosmetic Retailingreportable segmentcapex2021-07-01 → 2022-06-30¥5m
Functional Cosmetic Retailingreportable segmentdepreciation2021-07-01 → 2022-06-30¥11m
Functional Cosmetic Retailingreportable segmentrevenue2021-07-01 → 2022-06-30¥5.0bn
Functional Cosmetic Retailingreportable segmentrevenue external2021-07-01 → 2022-06-30¥5.0bn
Functional Cosmetic Retailingreportable segmentsegment assetsat 2022-06-30¥3.7bn
Functional Cosmetic Retailingreportable segmentsegment profit2021-07-01 → 2022-06-30¥1.1bn
Functional Food Retailingreportable segmentcapex2021-07-01 → 2022-06-30¥34m
Functional Food Retailingreportable segmentdepreciation2021-07-01 → 2022-06-30¥3m
Functional Food Retailingreportable segmentrevenue2021-07-01 → 2022-06-30¥2.7bn
Functional Food Retailingreportable segmentrevenue external2021-07-01 → 2022-06-30¥2.7bn
Functional Food Retailingreportable segmentsegment assetsat 2022-06-30¥1.3bn
Functional Food Retailingreportable segmentsegment profit2021-07-01 → 2022-06-30¥200m
Functional Material Developmentreportable segmentdepreciation2021-07-01 → 2022-06-30¥2m
Functional Material Developmentreportable segmentrevenue2021-07-01 → 2022-06-30¥569m
Functional Material Developmentreportable segmentrevenue external2021-07-01 → 2022-06-30¥558m
Functional Material Developmentreportable segmentrevenue intersegment2021-07-01 → 2022-06-30¥11m
Functional Material Developmentreportable segmentsegment assetsat 2022-06-30¥1.3bn
Functional Material Developmentreportable segmentsegment profit2021-07-01 → 2022-06-30¥83m
Health Care Support Servicereportable segmentcapex2021-07-01 → 2022-06-30¥709,000
Health Care Support Servicereportable segmentdepreciation2021-07-01 → 2022-06-30¥1m
Health Care Support Servicereportable segmentrevenue2021-07-01 → 2022-06-30¥549m
Health Care Support Servicereportable segmentrevenue external2021-07-01 → 2022-06-30¥549m
Health Care Support Servicereportable segmentsegment assetsat 2022-06-30¥330m
Health Care Support Servicereportable segmentsegment profit2021-07-01 → 2022-06-30¥117m
—segment totalcapex2021-07-01 → 2022-06-30¥45m
—segment totaldepreciation2021-07-01 → 2022-06-30¥20m
—segment totalrevenue2021-07-01 → 2022-06-30¥9.4bn
—segment totalrevenue external2021-07-01 → 2022-06-30¥9.3bn
—segment totalrevenue intersegment2021-07-01 → 2022-06-30¥11m
—segment totalsegment assetsat 2022-06-30¥7.2bn
—segment totalsegment profit2021-07-01 → 2022-06-30¥1.5bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 1,234
ItemContextValueUnit
Address major shareholdersCurrentYearInstant_No3MajorShareholdersMember
Original text (Japanese)東京都豊島区池袋1-8-5
Name major shareholdersCurrentYearInstant_No4MajorShareholdersMember
Original text (Japanese)天野 謙二郎
Address major shareholdersCurrentYearInstant_No4MajorShareholdersMember
Original text (Japanese)茨城県龍ケ崎市
Name major shareholdersCurrentYearInstant_No5MajorShareholdersMember
Original text (Japanese)野村證券株式会社
Address major shareholdersCurrentYearInstant_No5MajorShareholdersMember
Original text (Japanese)東京都中央区日本橋1-13-1
Name major shareholdersCurrentYearInstant_No6MajorShareholdersMember
Original text (Japanese)INTERACTIVE BROKERS LLC(常任代理人 インタラクティブ・ブローカーズ証券株式会社)
Address major shareholdersCurrentYearInstant_No6MajorShareholdersMemberText · Plus
Name major shareholdersCurrentYearInstant_No7MajorShareholdersMember
Original text (Japanese)日本証券金融株式会社
Address major shareholdersCurrentYearInstant_No7MajorShareholdersMember
Original text (Japanese)東京都中央区日本橋茅場町1-2-10
Name major shareholdersCurrentYearInstant_No8MajorShareholdersMember
Original text (Japanese)THE BANK OF NEW YORK MELLON 140040(常任代理人 株式会社みずほ銀行)
Address major shareholdersCurrentYearInstant_No8MajorShareholdersMember
Original text (Japanese)240 GREENWICH STREET,NEW YORK,NY 10286,U.S.A.(東京都港区港南2-15-1)
Name major shareholdersCurrentYearInstant_No9MajorShareholdersMember
Original text (Japanese)林 一弘
Address major shareholdersCurrentYearInstant_No9MajorShareholdersMember
Original text (Japanese)大阪府八尾市
Name major shareholdersCurrentYearInstant_No10MajorShareholdersMember
Original text (Japanese)松井証券株式会社
Address major shareholdersCurrentYearInstant_No10MajorShareholdersMember
Original text (Japanese)東京都千代田区麹町1-4
Issued shares voting rights (text)FilingDateInstantText · Plus
Description issued shares voting rightsCurrentYearInstant_SharesWithNoVotingRightsMember-
Description issued shares voting rightsCurrentYearInstant_SharesWithRestrictedVotingRightsTreasurySharesEtcMember-
Description issued shares voting rightsCurrentYearInstant_SharesWithRestrictedVotingRightsOtherMember-
Description issued shares voting rightsCurrentYearInstant_SharesWithFullVotingRightsTreasurySharesEtcMember-
Description issued shares voting rightsCurrentYearInstant_SharesWithFullVotingRightsOtherMember-
Description issued shares voting rightsCurrentYearInstant_SharesLessThanOneUnitMember-
Treasury shares etc (text)FilingDateInstantText · Plus
Classes of shares etc (text)FilingDateInstantText · Plus
Acquisitions by resolution of shareholders meeting (text)FilingDateInstantText · Plus
Acquisitions by resolution of board of directors meeting (text)FilingDateInstantText · Plus
Acquisitions not based on resolution of shareholders meeting or board of directors meeting (text)FilingDateInstantText · Plus
Disposals or holding of acquired treasury shares (text)FilingDateInstantText · Plus
Dividend policy (text)FilingDateInstantText · Plus
Date of resolution dividends of surplusFilingDateInstant_Row1Member2023-09-27
Resolution dividends of surplusFilingDateInstant_Row1Member
Original text (Japanese)定時株主総会決議
Overview of corporate governance (text)FilingDateInstantText · Plus
Corporate governance company with corporate auditors (text)FilingDateInstantText · Plus
Information about officers (text)FilingDateInstantText · Plus
Official title or position information about directors and corporate auditorsFilingDateInstant_jpcrp030000-asr_E05367-000IshigamiKentaroMember
Original text (Japanese)取締役社長(代表取締役)
Name information about directors and corporate auditorsFilingDateInstant_jpcrp030000-asr_E05367-000IshigamiKentaroMember
Original text (Japanese)石神賢太郎
Date of birth information about directors and corporate auditorsFilingDateInstant_jpcrp030000-asr_E05367-000IshigamiKentaroMember1973-01-05
Career summary information about directors and corporate auditors (text)FilingDateInstant_jpcrp030000-asr_E05367-000IshigamiKentaroMemberText · Plus
Term of office information about directors and corporate auditorsFilingDateInstant_jpcrp030000-asr_E05367-000IshigamiKentaroMember
Original text (Japanese)(注)3
Official title or position information about directors and corporate auditorsFilingDateInstant_jpcrp030000-asr_E05367-000KajimotoOsamiMember
Original text (Japanese)取締役(非常勤)
Name information about directors and corporate auditorsFilingDateInstant_jpcrp030000-asr_E05367-000KajimotoOsamiMember
Original text (Japanese)梶本 修身
Date of birth information about directors and corporate auditorsFilingDateInstant_jpcrp030000-asr_E05367-000KajimotoOsamiMember1962-03-24
Career summary information about directors and corporate auditors (text)FilingDateInstant_jpcrp030000-asr_E05367-000KajimotoOsamiMemberText · Plus
Term of office information about directors and corporate auditorsFilingDateInstant_jpcrp030000-asr_E05367-000KajimotoOsamiMember
Original text (Japanese)(注)3
Official title or position information about directors and corporate auditorsFilingDateInstant_jpcrp030000-asr_E05367-000SuginoTomohiroMember
Original text (Japanese)取締役
Name information about directors and corporate auditorsFilingDateInstant_jpcrp030000-asr_E05367-000SuginoTomohiroMember
Original text (Japanese)杉野 友啓
Date of birth information about directors and corporate auditorsFilingDateInstant_jpcrp030000-asr_E05367-000SuginoTomohiroMember1968-10-26
Career summary information about directors and corporate auditors (text)FilingDateInstant_jpcrp030000-asr_E05367-000SuginoTomohiroMemberText · Plus
Term of office information about directors and corporate auditorsFilingDateInstant_jpcrp030000-asr_E05367-000SuginoTomohiroMember
Original text (Japanese)(注)3
Official title or position information about directors and corporate auditorsFilingDateInstant_jpcrp030000-asr_E05367-000SumidaMasaoMember
Original text (Japanese)取締役

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 24 of 24 passed
balance sheet identityconsolidated 2022-06-30pass
balance sheet identityconsolidated 2023-06-30pass rounding
balance sheet identitynon_consolidated 2022-06-30pass
balance sheet identitynon_consolidated 2023-06-30pass rounding
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2021-06-30pass
statement vs summary · net assetsconsolidated 2022-06-30pass
statement vs summary · net assetsconsolidated 2023-06-30pass
statement vs summary · net assetsnon_consolidated 2021-06-30pass
statement vs summary · net assetsnon_consolidated 2022-06-30pass
statement vs summary · net assetsnon_consolidated 2023-06-30pass
statement vs summary · net income attributable to parentconsolidated 2021-07-01/2022-06-30pass
statement vs summary · net income attributable to parentconsolidated 2022-07-01/2023-06-30pass
statement vs summary · operating cash flowconsolidated 2021-07-01/2022-06-30pass
statement vs summary · operating cash flowconsolidated 2022-07-01/2023-06-30pass
statement vs summary · revenueconsolidated 2021-07-01/2022-06-30pass
statement vs summary · revenueconsolidated 2022-07-01/2023-06-30pass
statement vs summary · revenuenon_consolidated 2021-07-01/2022-06-30pass
statement vs summary · revenuenon_consolidated 2022-07-01/2023-06-30pass
statement vs summary · total assetsconsolidated 2022-06-30pass
statement vs summary · total assetsconsolidated 2023-06-30pass
statement vs summary · total assetsnon_consolidated 2022-06-30pass
statement vs summary · total assetsnon_consolidated 2023-06-30pass